Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma a phase II LYSA study

Roch Houot; Guillaume Cartron; Fontanet Bijou; Sophie de Guibert; Gilles A Salles; Christophe Fruchart; Krimo Bouabdallah; Marie Maerevoet; Pierre Feugier; Steven Le Gouill; Hervé Tilly; Rene-Olivier Casasnovas; Cécile Moluçon-Chabrot; Eric van den Neste; Pierre Zachee; Marc Andre; Christophe Bonnet; Corinne Haioun; Achiel van Hoof; Koen van Eygen; Lysiane Molina; Emmanuelle Nicolas-Virelizier; Philippe Ruminy; Franck Morschhauser

doi:10.1038/s41375-018-0282-y

$Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma a phase II LYSA study$

Journal article

Open access

Peer reviewed

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma a phase II LYSA study

Roch Houot, Guillaume Cartron, Fontanet Bijou, Sophie de Guibert, Gilles A Salles, Christophe Fruchart, Krimo Bouabdallah, Marie Maerevoet, Pierre Feugier, Steven Le Gouill, …

Leukemia, Vol.33(3), pp.776-780

03/2019

DOI: https://doi.org/10.1038/s41375-018-0282-y

PMID: 30291335

Abstract

Lenalidomide

Mantle cell lymphoma

Diffuse large B cell lymphoma

Obinutuzumab

Files and links (1)

url

Find in HALView

Metrics

1 Record Views

Details

Title: Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma a phase II LYSA study
Creators - without role: Roch Houot - Centre Hospitalier Universitaire de Rennes
Guillaume Cartron - Université de Montpellier, Laboratory of Pathogens and Host Immunity - LPHI
Fontanet Bijou
Sophie de Guibert - Centre Hospitalier Universitaire de Rennes
Gilles A Salles - Hôpital Lyon Sud
Christophe Fruchart - Charmo University
Krimo Bouabdallah - Centre Hospitalier Universitaire de Bordeaux
Marie Maerevoet - Institut Jules Bordet
Pierre Feugier - Inserm
Steven Le Gouill - Nantes Université
Hervé Tilly - Inserm
Rene-Olivier Casasnovas - Service d'Hématologie Clinique (CHU de Dijon)
Cécile Moluçon-Chabrot - Centre Hospitalier Universitaire de Clermont-Ferrand
Eric van den Neste - Cliniques Universitaires Saint-Luc
Pierre Zachee - AZ Groeninge
Marc Andre - CHU Dinant Godinne UCL Namur
Christophe Bonnet - University of Liège
Corinne Haioun - Hôpital Henri Mondor
Achiel van Hoof - AZ Sint-Jan
Koen van Eygen - Ziekenhuisnetwerk Antwerpen Stuivenberg
Lysiane Molina - Centre Hospitalier Universitaire de Grenoble
Emmanuelle Nicolas-Virelizier - Centre Léon Bérard
Philippe Ruminy - Inserm
Franck Morschhauser - Hôpital Claude Huriez
Publication Details: Leukemia, Vol.33(3), pp.776-780
Identifiers: 9938042309311
Academic Unit: Laboratory of Pathogens and Host Immunity - LPHI
Language: English
Resource Type: Journal article
Local Fields: hal-01903056